Janux Therapeutics Inc (JANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 260 | 220 | 200 | 0 | 0 |
| TOTAL | $260 | $220 | $200 | $N/A | $N/A |
| Non-Current Assets | |||||
| Other Non-Current Assets | 2,430 | 2,220 | 2,170 | 0 | 0 |
| TOTAL | $2,430 | $2,220 | $2,170 | $N/A | $N/A |
| Total Assets | $2,690 | $2,440 | $2,370 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 350 | 440 | 370 | 0 | 0 |
| Accrued Expenses | 500 | 730 | 460 | N/A | N/A |
| TOTAL | $2,567 | $1,456 | $2,260 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,567 | $1,456 | $2,260 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 11,050 | 10,570 | 9,800 | N/A | N/A |
| TOTAL | $11,050 | $10,570 | $9,800 | $N/A | $N/A |
| Total Liabilities And Equity | $13,617 | $12,026 | $12,060 | $0 | $0 |